These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15657370)

  • 1. Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study.
    Hedman M; Matikainen T; Föhr A; Lappi M; Piippo S; Nuutinen M; Antikainen M
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1942-52. PubMed ID: 15657370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
    Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
    JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
    Hedman M; Miettinen TA; Gylling H; Ketomäki A; Antikainen M
    J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.
    Knipscheer HC; Boelen CC; Kastelein JJ; van Diermen DE; Groenemeijer BE; van den Ende A; Büller HR; Bakker HD
    Pediatr Res; 1996 May; 39(5):867-71. PubMed ID: 8726243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability.
    Carreau V; Girardet JP; Bruckert E
    Paediatr Drugs; 2011 Aug; 13(4):267-75. PubMed ID: 21692550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia.
    Hedman M; Neuvonen PJ; Neuvonen M; Antikainen M
    Clin Pharmacol Ther; 2003 Aug; 74(2):178-85. PubMed ID: 12891228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagné C; Gaudet D; Morrison KM; Wiegman A; Turner T; Kusters DM; Miller E; Raichlen JS; Wissmar J; Martin PD; Stein EA; Kastelein JJP
    J Clin Lipidol; 2015; 9(6):741-750. PubMed ID: 26687694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Ryu SK; Hutten BA; Vissers MN; Wiegman A; Kastelein JJ; Tsimikas S
    J Clin Lipidol; 2011; 5(1):50-6. PubMed ID: 21262507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia.
    van der Graaf A; Nierman MC; Firth JC; Wolmarans KH; Marais AD; de Groot E
    Acta Paediatr; 2006 Nov; 95(11):1461-6. PubMed ID: 17062478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pravastatin on lipid transfer protein and lecithin cholesterol acyltransferase in heterozygous familial hypercholesterolemia.
    Fusegawa Y; Tada H; Oguma T; Shiina Y; Moriguchi EH; Tanabe T; Tamachi H; Tomoda H; Goto Y
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):81-6. PubMed ID: 7701533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia.
    Kusters DM; Avis HJ; de Groot E; Wijburg FA; Kastelein JJ; Wiegman A; Hutten BA
    JAMA; 2014 Sep; 312(10):1055-7. PubMed ID: 25203086
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
    Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
    Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
    Hedman M; Antikainen M; Holmberg C; Neuvonen M; Eichelbaum M; Kivistö KT; Neuvonen PJ; Niemi M
    Br J Clin Pharmacol; 2006 Jun; 61(6):706-15. PubMed ID: 16722833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.
    Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ
    Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RED-LIP study--pravastatin in primary isolated hypercholesterolemia--an open, prospective, multicenter trial.
    Sinzinger H; Pirich C
    Wien Klin Wochenschr; 1994; 106(23):721-7. PubMed ID: 7856175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
    Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.
    McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M
    Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of pravastatin on serum lipid levels in elderly patients with hypercholesterolemia.
    Morimoto S; Koh E; Fukuo K; Higaki J; Ikegami H; Miki T; Hata T; Ogihara T
    Clin Ther; 1994; 16(5):793-803. PubMed ID: 7859238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.